Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation
about
Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routesHIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.FluoroSpot Analysis of TLR-Activated Monocytes Reveals Several Distinct Cytokine-Secreting Subpopulations.Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans.Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.Comparison of ELISpot and FluoroSpot in the Analysis of Swine Flu-Specific IgG and IgA Secretion by in Vivo Activated Human B CellsValidation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring.A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imagingNovel immunological strategies for HIV-1 eradicationA plant protein signal sequence improved humoral immune response to HPV prophylactic and therapeutic DNA vaccines.Multifarious immunotherapeutic approaches to cure HIV-1 infectionStepping up ELISpot: Multi-Level Analysis in FluoroSpot AssaysRational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.Short noncoding DNA fragment improve efficiencies of in vivo electroporation-mediated gene transfer.DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficiency Virus Type 1 Clade C Envelope Vaccine
P2860
Q26865388-BE51946B-06D6-4028-BC77-61EE4AB14D56Q33743758-C48F08A7-4485-4C44-898A-E1926F3931B6Q33869332-69737EF6-4011-437A-8A96-0094559DDBABQ34220034-7555A476-2F72-4F27-9B58-72EDE204B036Q34271609-F25D2915-583C-42B0-89F2-F1C297EDE54EQ34394530-6C24A969-12EC-46A2-9E50-1557E7DADB75Q34414110-1E5A2719-CF63-4B90-B998-4D550ECBB6ADQ34530756-BB5D07D6-801D-4FB7-B04F-8A19E8358B61Q36494079-46403073-0A88-4645-9DEE-7E0164D9816BQ37530525-A8892F2B-09AB-4FE8-85C9-3E2998BB2A52Q38915896-1777E9D2-DE9B-45D1-8783-DA60800D4247Q40360089-85466BBA-CC3F-4059-8050-E88EBFEEC199Q41181556-60EA2A11-7426-46E1-BD37-D0F8F9DFF237Q42055826-8799B2B7-BBA2-4F1F-B082-E68F824A8158Q42411962-48CAFD69-006E-4987-BD3D-49BB1175E3D5Q44225799-3E8B3D90-80E8-45BD-A739-F71A0A29E7ACQ55493835-1C1D9857-ECF9-46A1-99E9-4EA117B271F3Q58727008-DD1AD2E4-9DBD-4F27-899C-33D8CD4D1626
P2860
Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparison of plasmid vaccine ...... dermal in vivo electroporation
@ast
Comparison of plasmid vaccine ...... dermal in vivo electroporation
@en
type
label
Comparison of plasmid vaccine ...... dermal in vivo electroporation
@ast
Comparison of plasmid vaccine ...... dermal in vivo electroporation
@en
prefLabel
Comparison of plasmid vaccine ...... dermal in vivo electroporation
@ast
Comparison of plasmid vaccine ...... dermal in vivo electroporation
@en
P2093
P2860
P50
P356
P1476
Comparison of plasmid vaccine ...... dermal in vivo electroporation
@en
P2093
Andreas Bråve
Anna-Karin Maltais
Eva Gelius
Kopek Nihlmark
P2860
P304
P356
10.1128/CVI.05045-11
P577
2011-07-13T00:00:00Z